Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...

Tesla CEO Elon Musk caused quite a stir recently when he humorously posed as an Ozempic Santa on Twitter, and gave Ozempic ...

Weight-loss drug stocks were catapulted into the spotlight in 2024, creating a lucrative, groundbreaking, and high-stakes ...

Elon Musk acknowledges using contentious weight-loss medication. 'Make America Healthy Again' won't be aided by drugs like ...

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has ... scale back his criticism of the new weight-loss drug amid his efforts to court support ...

Rise of the Rest Seed Fund managing partner JD Vance speaks onstage during Day 2 of TechCrunch Disrupt SF 2018 at Moscone ...

In an interview with Greg Gutfeld on Fox News in October, Kennedy suggested weight loss drugs were being pushed ... with newly prominent Trump adviser Elon Musk, who is co-lead of the ...